Congenital Hyperinsulinism International
                   

HI Global Registry Steering Committee

Below is a listing of the HI Global Registry Steering Committee, including the role of each member and additional organization information where applicable.

Jean-Baptiste Arnoux, MD, MSc, Scientific Advisor
Necker Children’s Hospital
Paris, France
http://hopital-necker.aphp.fr


Indi Banerjee, MBBS, MD, MRCPCH, Scientific Advisor
Consultant in Paediatric Endocrinology at the Royal Manchester Children’s Hospital
Clinical lead for the Northern Congenital Hyperinsulinism (NORCHI) service
Manchester, United Kingdom
http://www.cmft.nhs.uk/childrens-hospitals


Henrik Christesen, MD, PhD, Scientific Advisor
Odense University Hospital, Odense, Denmark
https://en.ouh.dk/


Antonia Dastamani, MD, Scientific Advisor
Consultant, Great Ormond Street Hospital for Children NHS
London, United Kingdom
https://www.gosh.nhs.uk/


Sarah Dearman, Patient Advocacy Advisor
Trustee of the Children’s Hyperinsulinism Fund
Watford, Hertfordshire, United Kingdom
https://www.hyperinsulinism.co.uk/


Diva D. De León-Crutchlow, MD, MSCE, Scientific Advisor
Director of the Congenital Hyperinsulinism Center, Children’s Hospital of Philadelphia,
Philadelphia, Pennsylvania, United States
https://www.chop.edu/centers-programs/congenital-hyperinsulinism-center


Sarah Flanagan, PhD, Scientific Advisor
Associate Professor in Genomic Medicine and Sir Henry Dale Research Fellow, University of Exeter
Exeter, United Kingdom
https://www.rdehospital.nhs.uk/


Ciara Grace, Patient Advocate
Trustee of the Children’s Hyperinsulinism Fund

Watford, Hertfordshire, United Kingdom

https://www.hyperinsulinism.co.uk/


Raphael Del Roio Liberatore Jr, MD, PhD, Scientific Advisor
Pediatric Endocrinologist at Ribeirão Preto Medical School, São Paulo University

Ribeirão Preto, SP Brazil

https://www.fmrp.usp.br/en/


Sandra Melo, PsyD, Patient Advocate


Klaus Mohnike, MD, Scientific Advisor
Magdeburg University Hospital
Magdeburg, Germany
https://www.med.uni-magdeburg.de/en/


Maria Paz Oviedo y, Patient Advocate


Tai Pasquini, MPA, PhD, Principal Investigator
CHI Research and Policy Director
East Longmeadow, MA, United States


Irene Promoussas, PhD, Patient Advocate


Julie Raskin, Chairperson and Co-Investigator
CHI Executive Director
Glen Ridge, NJ, United States


Abigail Ridler, Patient Advocate


Ulrike Seyfarth, Patient Advocate Chairman
Kongenitaler Hyperinsulinismus e.V
https://www.hyperinsulinismus.de/


Pratik Shah, MB BS, DCH, MRCPCH, PhD, Scientific Advisor
Consultant Paediatric Endocrinologist, Royal London Children’s Hospital, Barts Health NHS Trust
London, United Kingdom
https://children.bartshealth.nhs.uk/the-royal-london-hospital


Charles Stanley, MD, Scientific Advisor
Founder of the Congenital Hyperinsulinism Center, Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
https://www.chop.edu/centers-programs/congenital-hyperinsulinism-center


Paul Thornton, MB, BCh, MRCPI, DCh, Scientific Advisor
Medical Director, Endocrine and Diabetes Program
Head of Hyperinsulinism Center, Cook Children’s Hospital, Fort Worth, Texas, United States
https://www.cookchildrens.org/endocrinology/specialty-programs/Pages/hyperinsulinism-center.aspx


Lora (Bartocci) Van Arsdell, PsyD, LCSW, Patient Advocate